XML 43 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Stock Options Awards and Restricted Stock Grants (Details)
 3 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted average exercise price, granted $ 0.81
Share-Based Payment Arrangement, Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Options outstanding, beginning balance | shares 1,645,873
Weighted average exercise price, beginning balance $ 1.95
Options outstanding, granted | shares 321,750
Weighted average exercise price, granted $ 0.86
Options outstanding, Terminated | shares (25,272)
Weighted average exercise price, Terminated $ 1.49
Options outstanding, ending balance | shares 1,942,351
Weighted average exercise price, ending balance $ 1.78
Weighted average contractual terms 8 years 8 months 12 days
Options outstanding, exercisable | shares 1,095,121
Weighted average exercise price, exercisable $ 2.30
Weighted average contractual terms, exercisable 8 years 3 months 18 days
Options outstanding, aggregate intrinsic value, exercisable | $ $ 19,431
Restricted Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Non-vested stock awards, beginning balance | shares 39,700
Weighted average grant date fair value, beginning balance $ 0.99
Non-vested stock awards, granted | shares
Weighted average grant date fair value, granted
Non-vested stock awards, Terminated | shares
Weighted average grant date fair value, Terminated
Non-vested stock awards, ending balance | shares 39,700
Weighted average grant date fair value, ending balance $ 0.99